ModernVivo Launches Marketplace Service to Help Preclinical Teams Find the Right CRO for Their Study Faster

SEATTLE, Sept. 15, 2026 /PRNewswire/ -- ModernVivo, a company dedicated to helping preclinical R&D teams design their in vivo studies in a fraction of the time required by manual methods, has announced the launch of the ModernVivo Marketplace, which helps researchers identify pre-vetted CROs with the technical capabilities required to execute their studies.

Once a study design is finalized, the pressure to move toward execution begins, and delays and inefficiencies can emerge almost immediately. Researchers face a long process of identifying and qualifying suitable CROs to execute their study designs, often requiring highly specialized capabilities that can be difficult to assess. This process can take months, consuming valuable time and resources, threatening project viability, and delaying the progression of drugs into clinical trials.

The ModernVivo Marketplace solves this challenge by intelligently connecting biotech and pharmaceutical teams with the right CRO in days rather than months. Instead of matching studies and vendors based on broad therapeutic areas alone, the ModernVivo Marketplace accounts for the specific models, endpoints, and protocol requirements that define each project. This helps teams rapidly identify the CRO best suited to execute their studies from a growing network of vendors across North America, Europe, and Asia-Pacific.

• For preclinical teams, the ModernVivo Marketplace means faster, more confident development using a platform that already understands the niche requirements of their project and removes the guesswork.
• For CROs, the ModernVivo Marketplace provides pre-qualified leads by connecting them with researchers whose study requirements already align with their technical capabilities. With ModernVivo, CROs become immediately visible to relevant, high-fit opportunities.

"We are the only platform that not only helps teams design their study but also facilitates connections to the groups that can actually execute the experiment. Our goal is to make development as seamless as possible, and connecting research teams with CROs is another big step towards that goal. The ModernVivo Marketplace is free to use for teams using ModernVivo Scholar, as well as those new to ModernVivo. Ultimately, this product will mean faster drug development, helping potential cures and treatments reach the clinic sooner."
- Ian Levine, Co-Founder and CEO at ModernVivo

About ModernVivo

ModernVivo is a literature intelligence platform built for preclinical drug discovery and development. Designed by in vivo scientists, the platform analyzes millions of peer-reviewed publications to help researchers identify relevant in vivo models, extract granular experimental conditions, and cross-reference findings with clinical trial data and regulatory guidance. ModernVivo helps research teams design experiments in a fraction of the time required by traditional methods. The ModernVivo Marketplace extends that mission from study design to study execution by helping researchers connect with CROs that have the technical capabilities required to perform their studies. ModernVivo helps preclinical teams move from question to design to execution with greater speed and confidence.

To learn more about ModernVivo, visit www.modernvivo.com

General Inquiries:
[email protected]

Media Contact:
Ian Levine
425-390-4522
[email protected]

SOURCE ModernVivo